Kefrox 250mg/5ml Suspension 50ml
KSh 800.00
Kefrox 250mg/5ml Suspension (50ml) is a second-generation cephalosporin antibiotic that treats bacterial infections. It contains 250mg of Cefuroxime and is available in a tasty liquid form, making it easy for children and adults to take.
Anti-Biotics
Suggested Use
Kefrox 250mg/5ml Suspension is indicated for the treatment of infections caused by susceptible bacteria, including:
- Upper respiratory tract infections: sinusitis, tonsillitis, and pharyngitis.
- Lower respiratory tract infections: bronchitis and pneumonia.
- Urinary tract infections: cystitis and pyelonephritis.
- Skin and soft tissue infections: cellulitis and impetigo.
- Otitis media (middle ear infections).
- Lyme disease in early stages (as determined by a healthcare provider).
Dosage:
- Adults and Children (>12 years):
250-500mg (5ml-10ml) twice daily depending on the severity of the infection. - Children (3 months–12 years):
10-15mg/kg body weight twice daily. The maximum dose should not exceed 500mg/day. - Administration:
- Shake the bottle well before use.
- Administer with or after meals to enhance absorption and minimize stomach upset.
- Always use the provided measuring device for accurate dosing.
The specific dosage and duration should be as prescribed by a healthcare professional.
Warning
- Do not use Kefrox if the patient has a known allergy to cefuroxime, other cephalosporins, or penicillins.
- Dose adjustments may be required in patients with renal dysfunction.
- Cefuroxime may cause Clostridium difficile-associated diarrhoea; discontinue and seek medical attention if severe diarrhoea occurs.
- Pregnancy and breast-feeding: Use only if the potential benefit outweighs the risk as determined by a doctor.
- Avoid using with strong diuretics or nephrotoxic drugs to reduce the risk of kidney damage.
- Keep refrigerated (2°C to 8°C) after reconstitution. Discard unused suspension after 10 days.
Always follow your doctor’s instructions and complete the full course of therapy even if symptoms improve.